148 related articles for article (PubMed ID: 22929887)
1. Human responses against HER-2-positive cancer cells in human immune system-engrafted mice.
De Giovanni C; Nicoletti G; Landuzzi L; Romani F; Croci S; Palladini A; Murgo A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Iezzi M; Stramucci L; Barbieri E; Lemoli RM; Nanni P; Lollini PL
Br J Cancer; 2012 Oct; 107(8):1302-9. PubMed ID: 22929887
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD133 on a human cell line lacking CD34.
Delfini C; Centis F; Falzetti F; Tabilio A
Leukemia; 2002 Oct; 16(10):2174-5; author reply 2175. PubMed ID: 12357381
[No Abstract] [Full Text] [Related]
4. Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells.
Sun JC; Pan K; Chen MS; Wang QJ; Wang H; Ma HQ; Li YQ; Liang XT; Li JJ; Zhao JJ; Chen YB; Pang XH; Liu WL; Cao Y; Guan XY; Lian QZ; Xia JC
Cancer Biol Ther; 2010 Aug; 10(4):368-75. PubMed ID: 20581468
[TBL] [Abstract][Full Text] [Related]
5. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
[TBL] [Abstract][Full Text] [Related]
6. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.
Whittington PJ; Radkevich-Brown O; Jacob JB; Jones RF; Weise AM; Wei WZ
Cancer Immunol Immunother; 2009 May; 58(5):759-67. PubMed ID: 18836716
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor.
Freund D; Oswald J; Feldmann S; Ehninger G; Corbeil D; Bornhäuser M
Cell Prolif; 2006 Aug; 39(4):325-32. PubMed ID: 16872366
[TBL] [Abstract][Full Text] [Related]
8. Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): assessment of cross-reacting monoclonal antibodies.
Shibata H; Hanazono Y; Ageyama N; Nagashima T; Ueda Y; Hasegawa M; Ozawa K; Yoshikawa Y; Terao K
Am J Primatol; 2003 Sep; 61(1):3-12. PubMed ID: 12966515
[TBL] [Abstract][Full Text] [Related]
9. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
[TBL] [Abstract][Full Text] [Related]
11. A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs).
Schmetzer O; Valentin P; Smorodchenko A; Domenis R; Gri G; Siebenhaar F; Metz M; Maurer M
J Immunol Methods; 2014 Nov; 413():62-8. PubMed ID: 25038510
[TBL] [Abstract][Full Text] [Related]
12. HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.
Landuzzi L; Antognoli A; Nicoletti G; Croci S; Palladini A; Ianzano ML; Murgo A; Stivani V; Grosso V; Nanni P; De Giovanni C; Lollini PL
Vaccine; 2011 Jun; 29(29-30):4690-7. PubMed ID: 21569812
[TBL] [Abstract][Full Text] [Related]
13. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency.
Slatter MA; Brigham K; Dickinson AM; Harvey HL; Barge D; Jackson A; Bown N; Flood TJ; Cant AJ; Abinun M; Gennery AR
J Allergy Clin Immunol; 2008 Feb; 121(2):361-7. PubMed ID: 18086494
[TBL] [Abstract][Full Text] [Related]
14. Biology and plasticity of CD133+ hematopoietic stem cells.
Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
[TBL] [Abstract][Full Text] [Related]
16. Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide.
Tobias J; Jasinska J; Baier K; Kundi M; Ede N; Zielinski C; Wiedermann U
BMC Cancer; 2017 Feb; 17(1):118. PubMed ID: 28183282
[TBL] [Abstract][Full Text] [Related]
17. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel PG; Niethammer D; Handgretinger R
Klin Padiatr; 2005; 217(6):334-8. PubMed ID: 16307419
[TBL] [Abstract][Full Text] [Related]
18. AC133+ G0 cells from cord blood show a high incidence of long-term culture-initiating cells and a capacity for more than 100 million-fold amplification of colony-forming cells in vitro.
Summers YJ; Heyworth CM; de Wynter EA; Hart CA; Chang J; Testa NG
Stem Cells; 2004; 22(5):704-15. PubMed ID: 15342935
[TBL] [Abstract][Full Text] [Related]
19. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
[TBL] [Abstract][Full Text] [Related]
20. Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice.
Drake AC; Khoury M; Leskov I; Iliopoulou BP; Fragoso M; Lodish H; Chen J
PLoS One; 2011 Apr; 6(4):e18382. PubMed ID: 21559522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
